SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade

11/12/2025 6 min
SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade

Listen "SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade"

Episode Synopsis

SpaceX is pushing ahead with its initial public offering plans – a bid to raise some $30 billion and land in the $1.5 trillion club – while the biotech sector has seen the most mergers and acquisitions in a decade, as pharma firms race against an expiry date.Today’s stories:SpaceX Is Preparing For Its Public Market Launch DayPharma Firms Rushed To Restock Before Their Pipelines Run DryTry Finimize Pro

More episodes of the podcast The Finimize Daily Brief